Related Experiment Videos
Evaluation of hepatocyte-specific paramagnetic contrast media for MR imaging of hepatitis
A Tanimoto1, B P Kreft, Y Baba
1Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston.
Abstract:
The hepatocyte-specific paramagnetic magnetic resonance (MR) contrast agents manganese-DPDP [N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'bis-(phosphate)] and gadobenate dimeglumine were used for diagnosing chemically induced hepatitis in rats. Ex vivo liver tissue relaxation times and in vivo MR image signal-to-noise ratios were compared before and after contrast agent administration. Ex vivo relaxometry and in vivo MR imaging showed that Mn-DPDP enhanced normal and diseased livers to the same degree at all time points from 5 to 120 minutes. Gadobenate dimeglumine showed reduced T1 and T2 enhancements in hepatitis relative to those of normal liver, in the early phase (5-30 minutes). However, these effects are offsetting, and as a result, MR imaging failed to allow distinction of diseased from normal livers. This surprising result observed in vivo was in fact predicted by applying the Bloch equation to our ex vivo data. Our results show that detection and quantitation of hepatitis with MR imaging enhanced with paramagnetic cell-specific contrast agents will be more difficult than anticipated.
Insights
Diagnosing chemically induced hepatitis in rats using MR imaging proved difficult. Hepatocyte-specific contrast agents like manganese-DPDP and gadobenate dimeglumine did not reliably distinguish diseased from healthy livers.
Area of Science:
- Hepatobiliary imaging
- Medical diagnostics
- Paramagnetic contrast agents
Background:
- Hepatitis diagnosis often relies on invasive methods.
- Hepatocyte-specific MRI contrast agents offer potential for non-invasive liver disease assessment.
- Distinguishing between normal and diseased liver tissue is crucial for accurate diagnosis.
Purpose of the Study:
- To evaluate the efficacy of hepatocyte-specific MRI contrast agents for diagnosing chemically induced hepatitis in rats.
- To compare the performance of manganese-DPDP and gadobenate dimeglumine in differentiating normal from diseased liver tissue.
- To assess the utility of ex vivo relaxometry and in vivo MRI for hepatitis detection.
Main Methods:
- Hepatitis was induced in rats.
- Ex vivo liver tissue relaxation times (T1 and T2) were measured before and after contrast agent administration.
- In vivo MR imaging signal-to-noise ratios were acquired.
- Data were analyzed using the Bloch equation for theoretical prediction.
Main Results:
- Manganese-DPDP showed similar enhancement in both normal and diseased livers across all time points.
- Gadobenate dimeglumine exhibited reduced T1 and T2 enhancements in hepatitis during the early phase, but these effects were offsetting.
- In vivo MR imaging failed to distinguish diseased from normal livers with either contrast agent.
- Ex vivo relaxometry data, when analyzed with the Bloch equation, predicted the in vivo imaging outcomes.
Conclusions:
- Detection and quantification of hepatitis using MR imaging with hepatocyte-specific paramagnetic contrast agents may be more challenging than previously assumed.
- The offsetting effects of gadobenate dimeglumine's T1 and T2 changes limit its utility in differentiating hepatitis.
- Further research is needed to develop more effective MR imaging strategies for hepatitis diagnosis.